- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Cost-Effectiveness of Blood Glucose Monitoring Is Controversial
TO THE EDITORS
:
VA Center for Medication Safety, Hines VA
Center for Health Equity Research and Promotion, VA
School of Pharmacy
VA Greater Los Angeles Healthcare System
Los Angeles, California
Funding: None reported.
Author Disclosure: The authors report no relationship or financial interest with any entity that would pose a conflict of interest with the subject matter of this article.
Address correspondence to: Sherrie L. Aspinall, PharmD, MSc, VA Pittsburgh Healthcare System, Center for Health Equity Research and Promotion (151C-H), 7180 Highland Dr, Pittsburgh, PA 15206. E-mail: sherrie.aspinall@med.va.gov.
References
2. Karter AJ, Parker MM, Moffet HH, et al. Longitudinal study of new and prevalent use of self-monitoring of blood glucose. Diabetes Care. 2006;29(8):1757-1763.
4. Davidson MB, Castellanos M, Kain D, Duran P. The effect of self monitoring of blood glucose concentrations on glycated hemoglobin levels in diabetic patients not taking insulin: a blinded, randomized trial. Am J Med. 2005;118(4):422-425.
IN REPLY
:
Health Economics and Outcomes Research
Noblesville, IN
Funding: LifeScan, A Johnson and Johnson Company.
Author Disclosures: The authors (SLT, MEM) are employees of IMS, a company that provides contracted research consulting to LifeScan.
Address correspondence to: Sandra L. Tunis, PhD, Health Economics and Outcomes Research, IMS Consulting Services, 14701 Cumberland Rd, Ste 107, Nobelsville, IN 46060. E-mail: stunis@us.imshealth.com.
1.Tunis SL, Minshall ME. Self-monitoring of blood glucose in type 2 diabetes: cost-effectiveness in the United States. Am J Manag Care. 2008;14(3):131-140.
3. Centers for Disease Control and Prevention, National Center for Health Statistics. National Nutrition and Health Examination Survey (NHANES) data. Hyattsville, MD: US Department of Health and Human Services; 2000.
HEDIS Glycemic Goal Achieved Using Control-IQ Technology
December 22nd 2025A greater proportion of patients with type 1 diabetes who used automated insulin delivery systems vs multiple daily injections achieved the Healthcare Effectiveness Data and Information Set (HEDIS) glycemic measure.
Read More
Linking Data to Determine Risk for 30-Day Readmissions in Dementia
December 22nd 2025This study found that certain characteristics in linked electronic health record data across episodes of care can help identify patients with Alzheimer disease and related dementias at high risk of 30-day readmissions.
Read More
Performance of 2-Stage Health-Related Social Needs Screening Using Area-Level Measures
December 19th 2025Limiting health-related social needs screening to lower-income areas would reduce screening burdens; however, this study found a 2-stage screening approach based on geography to be suboptimal.
Read More
Impact of Medicaid Institution for Mental Diseases Exclusion on Serious Mental Illness Outcomes
December 17th 2025Medicaid’s Institution for Mental Diseases (IMD) rule bars federal funding for psychiatric facilities with more than 16 beds, but findings indicate that state waivers allowing treatment of serious mental illness in IMDs do not increase overall psychiatric hospitalizations.
Read More
